SETD2 and hepatocellular carcinoma: Finally, we studied the mechanism of action of SETD2 in HCC, and the RNA-seq results (Figure 4E) showed that SETD2 silencing inhibited the proliferation and migration of HCC cell lines through the fibroblast growth factor receptor (FGFR) signaling pathway.